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Introduction
Breast cancer is the most common malig-
nancy among women in the United States 
[American Cancer Society (ACS) 2011]. 
Polycyclic aromatic hydrocarbons (PAHs) 
are ubiquitous pollutants formed from 
incomplete combustion (Boström et al. 
2002). PAHs are genotoxic prooxidants, 
confirmed human lung carcinogens, and 
potent mammary carcinogens in laboratory 
animals [International Agency for Research 
on Cancer (IARC) 2010]. However, the asso-
ciation between PAHs and breast cancer in 
women is unclear (Gammon and Santella 
2008). Previous population studies have 
reported associations between PAH-related 
exposures and breast cancer. For example, 
PAHs bind to DNA, including in breast 
tissue, and the resulting DNA adducts have 
been associated with breast cancer in epide-
miological studies, although the research is 
scant (Gammon et al. 2002b; Rundle et al. 
2000). PAH–DNA adducts reflect short-term 
exposures (Gammon et al. 2002b), whereas 
breast cancer is thought to develop over many 
years. Thus, it is of interest to evaluate longer-
term PAH exposures in relation to breast 
cancer risk.
Vehicular traffic is a major ambient source 
of PAH exposure, especially near urban areas 
(Fromme et al. 2004). To our knowledge, 
all previous studies on traffic or air pollution 
exposure and breast cancer have reported 
some positive associations between breast 
cancer and at least one air pollution exposure 
surrogate (Bonner et al. 2005; Crouse et al. 
2010; Lewis-Michl et al. 1996; Nie et al. 
2007; Raaschou-Nielsen et al. 2011). In 
some cases, the effect estimates were close 
to the null [for example, 1.16 (0.89, 1.51); 
Raaschou-Nielsen et al. 2011]. The exposure 
assessment methods in these previous reports 
varied. Some investigations relied on simple 
traffic density data or sparse monitors, evalu-
ated relatively brief periods of exposure, or 
focused on nitrogen oxides rather than 
carcinogenic particulate pollution. Further 
progress requires sophisticated modeling to 
reconstruct long-term cumulative exposures to 
ambient PAHs.
Breast cancer risk factor profiles differ by 
menopausal status and tumor subtype (ACS 
2011; Chen and Colditz 2007), and fruits 
and vegetables may modify the carcinogenic 
effects of PAHs via antioxidant and other 
chemopreventive properties (Hecht 2000; 
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Background: Polycyclic aromatic hydrocarbons (PAHs) are widespread environmental  pollutants, 
known human lung carcinogens, and potent mammary carcinogens in laboratory animals. 
However, the association between PAHs and breast cancer in women is unclear. Vehicular traffic is 
a major ambient source of PAH exposure.
oBjectives: Our study aim was to evaluate the association between residential exposure to 
 vehicular traffic and breast cancer incidence.
Methods: Residential histories of 1,508 participants with breast cancer (case participants) and 
1,556 particpants with no breast cancer (control participants) were assessed in a population-based 
investigation conducted in 1996–1997. Traffic exposure estimates of benzo[a]pyrene (B[a]P), as a 
proxy for traffic-related PAHs, for the years 1960–1995 were reconstructed using a model previ-
ously shown to generate estimates consistent with measured soil PAHs, PAH–DNA adducts, and 
CO readings. Associations between vehicular traffic exposure estimates and breast cancer incidence 
were evaluated using unconditional logistic regression.
results: The odds ratio (95% CI) was modestly elevated by 1.44 (0.78, 2.68) for the association 
between breast cancer and long-term 1960–1990 vehicular traffic estimates in the top 5%, compared 
with below the median. The association with recent 1995 traffic exposure was elevated by 1.14 
(0.80, 1.64) for the top 5%, compared with below the median, which was stronger among women 
with low fruit/vegetable intake [1.46 (0.89, 2.40)], but not among those with high fruit/vegetable 
intake [0.92 (0.53, 1.60)]. Among the subset of women with information regarding traffic exposure 
and tumor hormone receptor subtype, the traffic–breast cancer association was higher for those with 
estrogen/progesterone-negative tumors [1.67 (0.91, 3.05) relative to control participants], but lower 
among all other tumor subtypes [0.80 (0.50, 1.27) compared with control participants].
conclusions: In our population-based study, we observed positive associations between vehicular 
traffic-related B[a]P exposure and breast cancer incidence among women with comparatively high 
long-term traffic B[a]P exposures, although effect estimates were imprecise.
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exposure and breast cancer incidence: the Long Island Breast Cancer Study Project (LIBCSP). 
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Jin et al. 2006). However, whether the asso-
ciation between ambient PAHs and breast 
cancer varies by fruit/vegetable intake, tumor 
characteristics, or menopausal status is not 
well understood.
Our population-based study aimed to 
estimate the association between breast 
cancer incidence and vehicular traffic, overall 
and within subgroups of women classified 
according to fruit/vegetable intake, meno-
pausal status, and tumor subtype. For the 
study reported here, we used long-term, 
individualized residential traffic benzo[a]
pyrene (B[a]P) exposure estimates (as a 
proxy for exposure to particulate traffic 
PAHs), which were reconstructed using a 
historical, geographic exposure model that 
was consistent with a varied set of environ-
mental measurements (Beyea et al. 2006). It 
is important to help clarify the association 
between traffic PAHs and breast cancer given 
the high incidence of breast cancer and broad 
exposure to traffic pollution worldwide.
Materials and Methods
We used resources from the case–control 
component of the Long Island Breast Cancer 
Study Project (LIBCSP), a population-based 
investigation conducted among women 
residing in Nassau and Suffolk counties in 
Long Island, New York (Gammon et al. 
2002a). All participating institutions provided 
institutional review board approval for this 
study, and all participants gave their written 
informed consent prior to study enrollment.
Study population. Eligible case participants 
were diagnosed with a first primary invasive 
or in situ breast cancer between August 1996 
and July 1997 and were identified via rapid 
case ascertainment through contact with 
local pathology departments (Gammon et al. 
2002a). Eligible control participants were 
women with no history of breast cancer and 
were identified using random digit dialing 
(Waksberg 1978) for women < 65 years old 
and Health Care Finance Administration 
records for women ≥ 65 years old. Controls 
were frequency matched based on the expected 
5-year age distribution among the case partici-
pants. Case–control sample sizes taking into 
account LIBCSP subject selection proce-
dures, participation rates, and vehicular traffic 
exposure data availability are presented in the 
Supplemental Material, Table S1.
The respondents included 1,508 case 
participants and 1,556 control participants 
(82.1% and 62.7% of eligible participants, 
respectively), who ranged between 20 and 
98 years of age and were mostly postmeno-
pausal (67.4%) and white (92.8%); the racial 
distribution reflects that of the study counties 
at the time of data collection (Gammon et al. 
2002a). More than 50% of the study partici-
pants reported a household income ≥ $50,000 
in the year prior to the study interview 
(Gammon et al. 2002a). Among women with 
traffic exposure information in the year 1995, 
203 presented with in situ breast cancer and 
1,071 presented with invasive breast cancer.
In previous LIBCSP reports, we found 
that breast cancer incidence was associated 
with early age at menarche, few or no births, 
and little or no breastfeeding (Gammon et al. 
2002a; Shantakumar et al. 2007); increased 
body size (Eng et al. 2005); little or no 
physical activity (McCullough et al. 2012); 
low fruit/vegetable intake (Gaudet et al. 
2004); low flavonoid intake (Fink et al. 2007); 
increased blood levels of PAH–DNA adducts 
(Gammon et al. 2002b); long-term residen-
tial environmental tobacco smoke exposure 
(Gammon et al. 2004); and increased grilled/
smoked food intake (Steck et al. 2007).
Study questionnaire. Trained interviewers 
administered an at-home, 2-hr structured 
questionnaire within a few months of diag-
nosis (case participants) or study recruitment 
(control participants). Detailed questionnaire 
information included residential history, 
household income, educational attainment, 
race, religion, reproductive and medical histo-
ries, smoking, exogenous hormone use, and 
body size (Gammon et al. 2002a). A validated 
Block food frequency questionnaire (Block 
et al. 1986, 1990) was self-completed by 98% 
of case and control participants and assessed 
typical dietary intake during the year prior to 
the interview, including intake of fruits, fruit 
juices, and vegetables (Gaudet et al. 2004).
Tumor Subtypes. Medical records were 
abstracted for 1,402 case participants to 
ascertain tumor estrogen and progesterone 
receptor (ER/PR) status subtypes (Gammon 
et al. 2002a; Yang et al. 2011; Yasui and 
Potter 1999). Mutations in exons 5–8 of the 
tumor p53 gene (TP53) were determined 
using archived, paraffin-embedded tissue 
(n = 859) (Rossner et al. 2009). Briefly, the 
extracted tumor DNA was amplified using 
polymerase chain reaction (PCR), screened 
via the Surveyor Mutation Detection Kit 
(Transgenomic, Omaha, NE, USA), and 
possible mutations were confirmed with 
an ABI 3100 capillary sequencer (Applied 
Biosystems Inc, Foster City, CA, USA).
Traffic B[a]P exposure assessment . 
Interviewers collected information regarding 
participants’ lifetime residential histories in 
Nassau and Suffolk counties only. Addresses at 
which a woman resided for at least 1 year were 
recorded and geocoded using BLR software 
(now part of Geographic Data Technology 
Inc., Lebanon, NH). Digital street maps were 
based on Census “Tiger” maps (http://www.
census.gov/geo/maps-data/data/tiger.html), 
which provide residence numbers at the start 
and end of a straight line street segment. The 
locations of intervening residence numbers 
were obtained by linear interpolation. The 
percentage of addresses that geocoded success-
fully ranged between 60% in the 1960s and 
85% in 1995 (Beyea et al. 2005), and 87% of 
participants provided at least one address that 
geocoded to the street level.
The traffic B[a]P exposure model (Beyea 
et al. 2005, 2006, 2013) used a road network 
comprising approximately 500,000 street 
segments in the New York metropolitan area, 
which includes Nassau and Suffolk counties. 
Emissions for each street segment were calcu-
lated as the product of hourly roadway-specific 
traffic counts and average U.S. tailpipe emis-
sions for the years 1960, 1970, 1980, and 
1990. Estimates for other years between 1960 
and 1995 were derived via interpolation or 
extrapolation. Vehicular traffic B[a]P estimates 
included adjustment for acceleration/decel-
eration at intersections (Beyea et al. 2006). 
Emissions within 80 km of the study area were 
directly calculated, and the exposure model 
also included a background term (propor-
tional to exposures from the 22 counties just 
outside of the 2-county study area) to account 
for more distant roads (Beyea et al. 2006). 
Tailpipe emission parameters were derived 
from road tunnel measurements throughout 
the United States and were checked using 
measurements on vehicles run on dynamom-
eter test beds (Beyea et al. 2008). As previously 
reported by Beyea et al. (2006), roadway traffic 
counts were obtained from over 13,000 annual 
average daily traffic measurements recorded in 
state and county records. All roads for which 
traffic counts were collected on Long Island 
by New York State, New York City, and 
Nassau and Suffolk counties were included in 
the direct emission model. Traffic counts for 
Nassau and Suffolk counties were taken from 
paper maps and entered into a geographic 
information system (see Supplemental 
Figure S1). For other counties, those roads 
for which counts were collected by New York 
State were included. Additional road counts 
were assumed to be proportional to the counts 
on major roads. Then, it was possible to scale 
“outer county” emissions to estimate total 
emissions from these counties, obtaining the 
scale factor as part of the fit to soil PAH data in 
the yards of study participants.
Roadway emissions were translated into 
predicted residential ambient B[a]P concen-
trations, considered a surrogate for exposure 
to all traffic PAHs, using standard meteo-
rological dispersion and deposition models 
(Beyea et al. 2006; Chock 1978; Viegele and 
Head 1978). Up to 100 m from a road, traffic 
B[a]P levels were estimated using highway 
line-source puff models (Chock 1978). 
Beyond 100 m, a standard Gaussian plume 
model with Briggs dispersion parameters 
(Viegele and Head 1978), which incorpo-
rated data on wind speed and direction, rain 
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washout, photo decay, and particle deposition, 
was used (Beyea et al. 2006). Meteorological 
data were collected at Brookhaven National 
Laboratory (year 1993), which was used as 
the standard for all years between 1960 and 
1995. Changing the year (1990) or location 
(MacArthur Airport) of meteorological data 
collection for a sensitivity analysis did not 
appreciably alter exposure estimates (Beyea 
et al. 2005).
Model validation. The exposure model was 
modified to predict measured residential soil 
and carpet PAH levels among women living 
at their current address for at least 15 years, 
PAH–DNA adduct levels in circulating 
mononuclear cells collected at the time of the 
interview, and monitoring data for carbon 
monoxide, a traffic-related pollutant. Details 
of the model validation process are described 
by Beyea et al. (2006). Briefly, the model 
predicted soil PAHs, PAH–DNA adduct 
levels, and carbon monoxide concentrations, 
but not PAH levels in carpet dust. Specifically, 
when model predictions were compared with 
soil data, no deviation from linearity was 
apparent, and the R2-value was 86%. The fit 
to quantile data for PAH–DNA adducts was 
similar, though not quite as strong, with an 
R2-value of 58%. When examining the fit of 
the model to hourly CO data, the R2-value 
was 63%, even though the R2-value for the 
correlation between hourly CO emissions and 
concentrations was only 3.3% owing to the 
lag between CO emissions from tailpipes and 
the time of reaching distant receptors. Finally, 
although our model predicted that carpet PAH 
levels would diminish across zones of urbaniza-
tion, the carpet PAH levels actually peaked at 
the center of the “zones” (Beyea et al. 2006). 
The latter finding is consistent with a study 
showing that residential ambient PAH concen-
trations do not correlate with house dust PAH 
levels (Fromme et al. 2004).
The model was calibrated against soil and 
PAH–DNA adduct data through chi-squared 
minimization (Beyea et al. 2006). The soil-
calibrated model provided the best fit to field 
data and was therefore used for regressions 
against breast cancer incidence. Emissions 
during engine warm-up, which were included 
during model building, did not contribute 
to predicting soil PAH levels in validation 
exercises and were dropped from the exposure 
model (Beyea et al. 2006).
Missing exposure data. Residential histo-
ries during 1960–1995 were incomplete for 
study participants who migrated to Long 
Island from other locations or whose recollec-
tion of prior addresses was incomplete (Beyea 
et al. 2013). We estimated emissions during 
these time periods by imputing values for 
the dispersion or transfer of emissions from 
the entire road network to exposure at indi-
vidual residences, referred to as the D-value. 
D-values tend to be roughly constant over 
historical time, changing only as the relative 
traffic pattern changes in different parts of the 
modeling region.
For time spent outside of the study area, 
we used a random variable with a lognormal 
distribution whose mean was the average esti-
mated traffic B[a]P concentration on Long 
Island during the relevant period, based on 
5-year intervals. We used multiple imputation 
(MI) to derive the variance of the random 
D-value, which was set equal to the variance of 
D-values for women in the study area during 
the same 5-year interval used to compute the 
mean (Beyea et al. 2013; Rubin 1996).
When the specific location of a residence 
within the Long Island study area was not 
known, the D-value was imputed by interpo-
lating between values at residences before and 
after the missing value (Beyea et al. 2013), as 
suggested by Raaschou-Nielsen et al. (2011). 
To obtain values that differed between 
imputed data sets, we multiplied the interpo-
lated D-value by a random number with a log 
normal distribution whose variance was taken 
from a lognormal fit to the two D-values used 
for interpolation. If the missing D-value was 
the first or last D-value for a study partici-
pant, extrapolation was used. For each of 
30 imputed data sets, distinct values were 
randomly drawn from the derived lognormal 
distributions used to pick imputed D-values.
Statistical methods. We evaluated cumula-
tive vehicular traffic B[a]P exposures for the 
year 1995 (the year prior to case ascertain-
ment) and for the period 1960–1990. For 
1995 exposures, we conducted a complete 
case analysis (CCA), in which all partici-
pants had complete, unimputed exposure 
information. For 1960–1990 exposures, we 
restricted analyses to women with ≤ 20% 
of their total cumulative exposure imputed 
(Beyea et al. 2013). We also conducted a 
sensitivity analysis restricting allowed imputa-
tion percentage by exposure duration rather 
than percentage of cumulative exposure level, 
as well as conducting a CCA for associations 
with 1960–1990 exposure. We selected a range 
of exposure durations in order to maximize 
study power, which was higher for recent 
exposures, in addition to benefiting from long-
term cumulative exposure information. We 
also removed the contribution of intersections 
from the exposure model and imputed missing 
exposures according to census place (i.e., city, 
town, or village) (Beyea et al. 2013). Emissions 
at intersections contribute strongly to total 
traffic PAH exposure because of the increased 
acceleration/deceleration that takes place in 
these locations (Beyea et al. 2006).
We calculated descriptive statistics for the 
exposure variables, overall and by case–control 
status, and evaluated Spearman and Pearson 
correlations (Rothman et al. 2012) between 
selected exposure variables. Pearson correla-
tion is more sensitive to outliers and the upper 
tails of a distribution than Spearman correla-
tion. “Outlier” exposure estimates in our study 
reflected truly increased exposures for these 
individuals owing to proximity to heavily traf-
ficked intersections (Beyea et al. 2006, 2013). 
Thus, Pearson coefficients may be informative 
when considering women with the highest 
exposure levels, but Spearman coefficients are 
likely to be more representative of the overall 
ranking for most participants.
Exposure levels were normalized to the 
average B[a]P exposure in 1995 and expressed 
as relative units (Beyea et al. 2013) in order to 
avoid interpreting results as stemming from 
specific B[a]P exposure levels; rather, B[a]P is 
to be considered a proxy for all traffic PAHs.
Statistical analyses were performed using 
SAS version 9.3 (SAS Institute Inc., Cary, NC).
Prior to undertaking regression analyses, 
we used age-adjusted cubic smoothing splines 
with knots at each unique exposure value 
(Hastie and Tibshirani 1990) to evaluate 
the association between traffic-related B[a]P 
exposure (during 1995 and 1960–1990) and 
breast cancer incidence. The spline figures 
for both short- and long-term exposures 
indicated that the association was not linear 
(data not shown) and were used to generate 
traffic B[a]P quantile cut points for regres-
sion models: < 50th (referent), 50th to < 75th, 
75th to 95th, and ≥ 95th percentiles. We are 
precluded from showing these figures because 
of stipulations in the LIBCSP’s consent forms 
and IRB approval regarding presenting results 
for individual women or groups comprising 
fewer than five participants because the figures 
would single out women with high traffic 
PAH exposure levels.
We used unconditional logistic regression 
(Hosmer and Lemeshow 1989) to estimate 
odds ratios (ORs) and 95% confidence inter-
vals (CIs) for associations between traffic 
B[a]P estimates and breast cancer incidence. 
When using partially imputed exposure vari-
ables, effect estimates and confidence limits 
were combined across 30 imputations using 
Rubin’s rules (Rubin 1996).
All regression models were adjusted 
for the case–control frequency-matching 
factor, 5-year age group (Gammon et al. 
2002a). Other potential confounders 
[educational level (less than high school, 
high school graduate, some college, college 
graduate, or post-college), annual household 
income (< $15,000, $15,000–$19,999, 
$20,000–$24,999, $25,000–$34,999, 
$35,000–$49,999, $50,000–$69,999, 
$70,000–$89,999, or ≥ $90,000), race (white, 
black, or other), religion (none, Protestant, 
Catholic, Jewish, or other), parity (contin-
uous), age at first birth (continuous), body 
mass index (kilograms per meter squared, 
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continuous) duration of oral contraceptive use 
(continuous), lifetime average alcohol intake 
(never drinkers, < 15 g/day, 15–30 g/day, 
≥ 30 g/day), lifetime average physical activity 
(in hours per week: none, low, average, and 
high), and duration of breastfeeding (contin-
uous)] were identified by a thorough literature 
review and analysis of directed acyclic graphs 
(Shrier and Platt 2008) and were evaluated 
for model inclusion using a 10% change-
in-estimate criterion relative to age-adjusted 
models (Rothman et al. 2012). No covariates 
altered age-adjusted effect estimates for the 
year 1995 or for the period 1960–1990 by 
10% or more. We present the results as age-
adjusted models as well as models adjusted for 
all potential confounders.
We explored effect modification by meno-
pausal status (pre- vs. postmenopausal) and by 
fruit/vegetable intake in the year prior to the 
study interview (≤ 34 vs. ≥ 35 servings/week) 
for 1995 and 1960–1990 exposures using 
stratified analyses and likelihood ratio tests 
for multiplicative interaction (Rothman et al. 
2012). Menopausal status was defined using 
data from the study questionnaire, which was 
collected during the case–control interview 
(Shantakumar et al. 2007). Specifically, meno-
pausal status was defined according to infor-
mation on participants’ last menstrual period, 
history of hysterectomy or bilateral oophorec-
tomy, smoking status, and hormone replace-
ment therapy use (Shantakumar et al. 2007). 
Fruit/vegetable intake was dichotomized based 
on previously reported associations with breast 
cancer incidence in the LIBCSP (Gaudet 
et al. 2004).
We used age-adjusted polytomous logistic 
regression models (Hosmer and Lemeshow 
1989) to estimate associations between traffic 
B[a]P and breast cancer, with cases categorized 
according to tumor TP53 mutation status 
and hormone receptor status subtypes and 
by whether tumors presented as invasive or 
in situ. Polytomous regression simultaneously 
generates effect estimates for several groups in 
relation to control participants. The ratios of 
the odds ratios and 95% CIs (Schlesselman 
1982) for these associations were then used 
to formally evaluate the heterogeneity of the 
effect estimates across tumor types [TP53 
mutation-positive vs. TP53 mutation- 
negative, in situ vs. invasive, ER+PR+ vs. 
all other subtypes (ER–/PR+, ER+/PR–, or 
ER–/PR–), and ER–PR– vs. all other subtypes 
(ER+/PR–, ER–/PR+, or ER+/PR+)]. The 
upper exposure quantiles (75th to < 95th and 
≥ 95th percentiles) were collapsed when cell 
sizes comprised fewer than 10 participants.
Results
The number of LIBCSP respondents for 
whom traffic B[a]P estimates were available 
(520–1,274 case participants; 566–1,334 
control participants) varied according to the 
exposure definition and the imputed data set 
(some women exceeded the limit on imputa-
tion percentage in certain imputation draws), 
and the participants showed a wide range of 
exposure levels (Table 1). Mean estimated 
exposures were consistently higher among 
case particpants than control participants 
(Table 1). In the year 1995, mean exposures 
were 1.03 and 0.97 units for participants 
in the case and control groups, respectively. 
The corresponding mean levels for cumula-
tive exposure in 1960–1990 were 227.42 and 
196.71 units, where each unit corresponds to 
one year’s worth of average exposure in 1995.
Short-term (1995) and long-term 
[1960–1990 (20% MI)] exposure estimates 
were correlated (Spearman correlation coeffi-
cient: r = 0.76, Pearson correlation coefficient: 
r = 0.41; see Supplemental Material, Table S2).
Adjusted cubic spline figures suggested 
an increase in breast cancer incidence among 
women with the top 1% of traffic B[a]P 
exposure levels in 1995 and in 1960–1990 
(data not shown). These results are based on 
a small number of women. Hence, we used 
broader quantiles (≥ 95th percentile, 75th to 
< 95th percentile, 50th to < 75th percentile, 
< 50th percentile) in regression models for 
1995 and 1960–1990 in order to stabilize 
the results, which are presented in Table 2. 
Age-adjusted ORs from logistic regression 
models comparing participants with the top 
5% of exposure levels to those with expo-
sures below the median were 1.14 (95% CI: 
0.80, 1.64) for 1995 exposure (complete case 
analysis), and 1.44 (95% CI: 0.78, 2.68) 
for cumulative exposure during 1960–1990 
(among women with ≤ 20% of their total 
exposure based on imputed values) (Table 2). 
Effect estimates were similar when adjusting 
for the full set of potential confounders, espe-
cially for the 1960–1990 results (Table 2). 
Restricting participants’ imputation percentage 
by exposure duration rather than by percentage 
of cumulative exposure level did not alter 
results for the association between 1960–1990 
traffic PAHs and incident breast cancer (data 
not shown). Associations for 1960–1990 
(CCA) were also similar to the results for 
1960–1990 with 20% MI (data not shown). 
After removing the contribution of intersec-
tions from the exposure model, we observed 
null associations between traffic PAH exposure 
and breast cancer risk (even among women 
with the highest exposures) which is consistent 
with a previous LIBCSP report indicating the 
importance of intersection emissions to total 
exposure (Beyea et al. 2006). However, inter-
actions with fruit/vegetable intake were still 
evident (data not shown).
The traffic B[a]P-breast cancer association 
was positive among women with low fruit/
vegetable intake (Table 3), but not among 
women with high fruit/vegetable intake. 
For example, among women with low 
Table 1. Residential vehicular traffic benzo[a]pyrene exposure estimates by case–control status, Long 
Island Breast Cancer Study Project, 1996–1997.
Traffic PAH exposure yearsa
Cases (n = 1,508) Controls (n = 1,556)
n Mean (IQR) n Mean (IQR)
1995 (CCA) 1,274 1.03 (0.62) 1,334 0.97 (0.55)
1960–1990 (≤ 20% MI)b 520–551 227.42 (125.31) 566–597 196.71 (122.06)
Abbreviations: CCA, complete case analysis; IQR, interquartile range; MI, multiple imputation.
aExposure levels were normalized to the average B[a]P exposure in 1995 and expressed as relative units in order to 
avoid interpreting results as stemming from specific B[a]P exposure levels. Rather, B[a]P is to be considered a proxy for 
all traffic PAHs. Mean values for multiple years represent cumulative versus mean annual exposure.  bCombined over 30 
imputations. Sample size varies across imputed data sets.
Table 2. Associations between varying time ranges of exposure to benzo[a]pyrene from residential 
vehicular traffic and breast cancer incidence, Long Island Breast Cancer Study Project, 1996–1997.
Traffic PAH exposure years/
percentile of exposure
Age-adjusted models Fully-adjusted modelsa
Cases Controls OR (95% CI) Cases Controls  OR (95% CI)
1995 (CCA)
< 50th 645 659 1.00 (referent) 606 620 1.00
50 to < 75th 299 353 0.87 (0.72, 1.04) 281 330 0.78 (0.63, 0.98)
75 to < 95th 260 261 1.01 (0.82, 1.23) 241 251 1.02 (0.80, 1.30)
≥ 95th 70 61 1.14 (0.80, 1.64) 67 58 1.06 (0.70, 1.60)
1960–1990 (≤ 20% MI)b
< 50th 262–287 289–320 1.00 (referent) 244–267 274–304 1.00
50 to < 75th 122–139 136–155 0.99 (0.73, 1.36) 113–130 126–142 0.97 (0.66, 1.42)
75 to < 95th 96–111 111–121 0.95 (0.68, 1.32) 88–104 104–113 0.92 (0.61, 1.39)
≥ 95th 24–29 19–21 1.44 (0.78, 2.68) 23–28 16–18 1.47 (0.70, 3.08)
Abbreviations: CCA, complete case analysis; CI, confidence interval; MI, multiple imputation; OR, odds ratio; PAH, 
polycyclic aromatic hydrocarbon.
aAdjusted for 5-year age group, educational level, annual household income, race, religion, parity, age at first birth, body 
mass index (kg/m2), duration of HRT use, duration of oral contraceptive use, lifetime average alcohol intake, lifetime 
average physical activity, and duration of breastfeeding. bCombined over 30 imputations. Sample size varies across 
imputed data sets.
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fruit/vegetable intake, we observed elevated 
ORs for the top 5% of 1995 exposures for this 
traffic PAH proxy compared with levels below 
the median (OR = 1.46; 95% CI: 0.89, 2.40, 
p for trend = 0.04). Among women with high 
fruit/vegetable intake, the corresponding OR 
was 0.92 (95% CI: 0.53, 1.60, p-interaction 
= 0.01). For 1960–1990 exposure, ORs for 
the top ≥ 75th percentile of exposure relative 
to exposures below the median were 1.43 
(95% CI: 0.94, 2.16) among those with low 
fruit/vegetable intake and 0.71 (95% CI: 
0.43, 1.15) among those with high fruit/
vegetable intake.
We observed some weak evidence that 
traffic B[a]P exposure and breast cancer inci-
dence may be more strongly related among 
premenopausal women (Table 3). For example, 
the OR for the association between breast 
cancer and 1995 traffic B[a]P exposure (≥ 95th 
percentile vs. below the median) was 1.20 
(95% CI: 0.58, 2.47) among premenopausal 
women, and 1.06 (95% CI: 0.69, 1.63) among 
postmenopausal women (p-interaction = 0.02). 
For 1960–1990 exposure, the ORs (≥ 75th 
percentile vs. below the median) were 1.31 
(95% CI: 0.63, 2.71) among premenopausal 
women and 0.91 (95% CI: 0.64, 1.29) among 
postmenopausal women (p-interaction = 0.50).
Traffic B[a]P exposure in 1995 (top 5% vs. 
below the median) was more strongly associ-
ated with ER–/PR– breast tumors (OR = 1.67; 
95% CI: 0.91, 3.05), rather than ER+/PR+, 
ER+/PR–, or ER–/PR+ tumors (OR = 0.80; 
95% CI: 0.50, 1.27; ratio of the ORs = 2.09; 
95% CI: 1.08, 4.06) (Table 4). ORs for 
women with exposures in the 50th to < 75th 
and 75th to < 95th percentile ranges were 
below the null value. The OR for traffic B[a]P 
in 1995 (top 5% vs. below the median) and 
ER+/PR+ breast tumors was 0.86 (95% CI: 
0.52, 1.41), versus 1.15 (95% CI: 0.68, 1.94) 
for ER+/PR–, ER–/PR+, or ER–/PR– tumors 
(Table 4). Among case women with available 
traffic PAH exposure estimates, 847 out of 
1,274 had information regarding their tumor 
hormone receptor status.
This traffic PAH proxy was also more 
strongly related to in situ rather than invasive 
breast cancers when evaluating women within 
Table 3. Associations between traffic benzo[a]pyrene exposure and breast cancer incidence within strata of fruit/vegetable intake and menopausal status, Long 
Island Breast Cancer Study Project, 1996–1997.
Traffic PAH exposure classification Cases (n) Controls (n) Age-adjusted OR (95% CI) Cases (n) Controls (n) Age-adjusted OR (95% CI) p for interactiona
Fruit/vegetable intakeb,c Low High
1995 (CAA) 0.01
< 50th percentile 404 431 1.00 (referent) 228 215 1.00 (referent)
50th to < 75th percentile 193 188 1.10 (0.86, 1.41) 98 159 0.58 (0.43, 0.80)
75th to < 95th percentile 156 132 1.24 (0.94, 1.62) 99 120 0.78 (0.56, 1.08)
≥ 95th percentile 42 30 1.46 (0.89, 2.40) 28 29 0.92 (0.53, 1.60)
p for trend 0.04 0.14
1960–1990 (≤ 20% MI)d,e 0.04
< 50th percentile 169–182 174–200 1.00 (referent)  89–105 100–113 1.00 (referent)
50th to < 75th percentile 79–92 73–84 1.19 (0.80, 1.77) 35–45 59–70 0.67 (0.39, 1.13)
≥ 75th percentile 79–89 56–64 1.43 (0.94, 2.16) 42–49 66–72 0.71 (0.43, 1.15)
p for trend 0.09 0.12
Menopausal statusf Premenopausal Postmenopausal
1995 (CCA) 0.02
< 50th percentile 190 229 1.00 (referent) 439 397 1.00 (referent)
50th to < 75th percentile 101 122 0.95 (0.68, 1.32) 193 222 0.79 (0.62, 1.00)
75th to < 95th percentile 91 67 1.64 (1.13, 2.38) 166 186 0.80 (0.62, 1.02)
≥ 95th percentile 16 16 1.20 (0.58, 2.47) 51 43 1.06 (0.69, 1.63)
p for trend 0.04 0.21
1960–1990 (≤ 20% MI)d,e 0.50
< 50th percentile 49–66 56–73 1.00 (referent) 209–228 210–240 1.00 (referent)
50th to < 75th percentile 23–29 29–38 0.84 (0.42, 1.66)  95–108 101–114 1.00 (0.70, 1.42)
≥ 75th percentile 23–29 19–26 1.31 (0.63, 2.71)  97–109 109–115 0.91 (0.64, 1.29)
p for trend 0.60 0.60
Abbreviations: CCA, complete case analysis; CI, confidence interval; MI, multiple imputation; OR, odds ratio.
ap-Values for interaction were derived using likelihood ratio tests. b ≥ 35 versus 0–34 servings/week (Gaudet et al. 2004). cn = 26 case participants and n = 30 control participants from 
the 1995 CCA were missing information for fruit/vegetable intake. dn = 27 case participants and n = 52 control participants from the 1995 CCA were missing information for menopausal 
status. eCombined over 30 imputations. Sample size varies across imputed data sets. fThe upper quantiles were combined to avoid cell sizes of < 10. The overall OR for the association 
between traffic exposure (≥ 75th vs. < 50th percentile) and breast cancer is 1.02 (95% CI: 0.75, 1.39).
Table 4. Odds ratios and 95% confidence intervals for the association between traffic benzo[a]pyrene 
exposure (1995) and tumor hormone receptor status subtypes (n = 847 case participants), Long Island 
Breast Cancer Study Project, 1996–1997.
Tumor category/percentile of exposure Cases Controls
Age-adjusted 
[OR (95% CI)]
Ratio of the ORs 
[OR (95% CI)]
ER+ and PR+ breast cancer
< 50th 281 659 1
50th to < 75th 105 353 0.69 (0.53, 0.90) 1.02 (0.72, 1.46)
75th to < 95th 94 261 0.82 (0.62, 1.08) 1.05 (0.72, 1.52)
≥ 95th 23 61 0.86 (0.52, 1.41) 0.74 (0.40, 1.38)
ER–/PR+, ER+/PR–, or ER–/PR– breast cancer
< 50th 192 659 1
50th to < 75th 70 353 0.68 (0.50, 0.91)
75th to < 95th 61 261 0.78 (0.57, 1.08)
≥ 95th 21 61 1.15 (0.68, 1.94)
ER– and PR– breast cancer
< 50th 97 659 1
50th to < 75th 41 353 0.79 (0.54, 1.16) 1.20 (0.79, 1.82)
75th to < 95th 31 261 0.81 (0.52, 1.24) 1.00 (0.64, 1.58)
≥ 95th 15 61 1.67 (0.91, 3.05) 2.09 (1.08, 4.06)
ER+/PR–, ER–/PR+, or ER+/PR+ breast cancer
< 50th 376 659 1
50th to < 75th 134 353 0.66 (0.52, 0.83)
75th to < 95th 124 261 0.81 (0.63, 1.03)
≥ 95th 29 61 0.80 (0.50, 1.27)
Abbreviations: CI, confidence interval; ER, estrogen receptor; OR, odds ratio from polytomous logistic regression; PAH, 
polycyclic aromatic hydrocarbon; PR, progesterone receptor.
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the top quantile of exposure compared with 
exposures below the median (Table 5). 
The ratios of the ORs were elevated (1.5 
and higher) for both 1995 and 1960–1990 
exposures. For example, for 1995 exposure, 
the ORs for the top quantile of exposure 
(vs. below the median) were 1.42 (95% CI: 
0.99, 2.02) for in situ tumors, and 0.97 
(95% CI: 0.80, 1.18) for invasive tumors (ratio 
of the ORs = 1.46, 95% CI: 1.02, 2.09).
We observed no heterogeneity of the effect 
estimates for tumor TP53-mutation status 
subtypes. Specifically, when compared with 
traffic PAH exposures below the median, 
effect estimates for exposures in the 50th to 
< 75th percentile and ≥ 75th percentile vacil-
lated around the null value for both 1995 
and 1960–1990 exposures, and the ratios of 
the ORs did not indicate tumor heteroge-
neity. For example, for 1960–1990 exposure 
(≥ 75th percentile vs. < 50th percentile), the 
observed ORs were 1.14 (95% CI: 0.52, 2.49) 
for tumor TP53-mutation positive cancer, 
and 1.00 (95% CI: 0.69, 1.44) for tumor 
TP53-mutation negative cancer.
Discussion
We observed a modest positive association 
between high-level residential exposure to 
vehicular traffic B[a]P, as a proxy for traffic 
PAHs, and breast cancer incidence in this 
population-based study, although estimates 
were imprecise and varied by the exposure 
duration examined. The age-adjusted odds 
ratios for the association were 1.14 (95% CI: 
0.80, 16.4) for recent 1995 traffic B[a]P 
exposure and 1.44 (95% CI: 0.78, 2.68) for 
long-term (1960–1990) exposure when 
comparing participants with exposure levels 
at or above the 95th percentile with partici-
pants with exposures under the median. 
The corresponding odds ratios for the asso-
ciation between recent exposure to this traffic 
PAH proxy and breast cancer were 1.46 
(95% CI: 0.89, 2.40) among women with 
low fruit/vegetable intake, and 1.67 (95% CI: 
0.91, 3.05) among those with hormone 
receptor–negative breast tumors. U.S. traffic 
PAH emissions are greatly reduced from the 
high levels of the 1960s and 1970s, but annual 
traffic kilometers driven is increasing (Beyea 
et al. 2008). Our results may have increased 
public health significance outside the United 
States, given widespread exposure to traffic 
pollution throughout the world and delayed 
introduction of vehicle pollution controls. 
For instance, tailpipe PAH reductions compa-
rable to those in the United States did not 
occur in Europe until the late 1990s (Beyea 
et al. 2008).
Traffic pollution is a major ambient 
source of indoor and outdoor ambient 
PAHs (Fromme et al. 2004; Nielsen 1996), 
especially near cities (Boström et al. 2002). 
Source apportionment studies conducted in 
urban areas have reported that approximately 
40–90% of ambient PAH levels are explained 
by vehicular traffic emissions, depending on 
various factors such as degree of urbaniza-
tion or day of the week (Harrison et al. 1996; 
Nielsen 1996).
Previous studies have consistently reported 
elevated associations between residential air 
pollution exposure and breast cancer risk 
(Bonner et al. 2005; Crouse et al. 2010; 
Lewis-Michl et al. 1996; Nie et al. 2007; 
Raaschou-Nielsen et al. 2011). For example, 
a breast cancer study conducted in Buffalo, 
New York, reported elevated odds ratios when 
comparing the highest and lowest quartiles 
of overall and traffic-related particulate pollu-
tion exposure in an area with high industrial 
emissions [OR = 2.42; 95% CI: 0.97, 6.09 
for exposure at birth, or OR = 2.57; 95% CI: 
1.16, 5.69 for exposure at the time of a 
woman’s first birth (Bonner et al. 2005; 
Nie et al. 2007)]. The latter study, by Nie 
et al. (2007), used an adapted version of the 
model developed for the LIBCSP. Other 
investigators examined continuous traffic-
related nitrogen oxide levels, reporting, for 
example, an elevated OR of 1.31 (95% CI: 
1.00, 1.71) for each 5-ppb increase in nitrogen 
dioxide (Crouse et al. 2010), or an OR of 1.16 
(95% CI: 0.89, 1.51) for each 100-μg/m3 
increase in nitrogen oxides (Raaschou-Nielsen 
et al. 2011). Finally, a study reported an 
elevated association between high residential 
traffic density in Nassau County but not 
Suffolk County in Long Island, NY [pollution 
levels are higher in Nassau County (Lewis-
Michl et al. 1996)]. The study by Lewis-Michl 
et al. (1996) was conducted in the same two 
counties as our investigation.
Some previous studies estimated exposure 
to air pollution, a complex mixture, using rela-
tively sparse monitors (Bonner et al. 2005), 
simple traffic density data (Lewis-Michl et al. 
1996), or reconstructed exposure to nitrogen 
oxides rather than carcinogenic particulate 
pollution (Crouse et al. 2010; Raaschou-
Nielsen et al. 2011). Two studies compared 
their exposure estimates against measured, 
related proxies (Nie et al. 2007; Raaschou-
Nielsen et al. 2011). Most studies evaluated 
relatively brief periods of exposure. Overall, 
based on an informal qualitative assessment, 
positive results were reported across studies 
despite differences in exposure assessment, 
exposure levels and timing, study design, 
and participant characteristics between 
study populations. When stratifying analyses 
by menopausal status, study results were 
inconsistent across investigations, suggesting 
that timing, magnitude of exposure, and/
or pollutant mix may play important roles, 
although such differences could also be 
explained by random chance.
Strengths of our study include long-term, 
individualized traffic B[a]P exposure esti-
mates generated from an exposure model that 
incorporated information regarding historical 
tailpipe emissions, local traffic patterns, mete-
orological conditions, pollutant dispersion, 
Table 5. Associations between exposure to traffic-related polycyclic aromatic hydrocarbons (PAHs) and 
invasive and in situ breast cancer incidence,a Long Island Breast Cancer Study Project, 1996–1997.
Traffic exposure years/percentile of exposure Cases Controls
Age-adjusted 
[OR (95% CI)] 




< 50th 87 659 1.0
50th to < 75th 56 353 1.20 (0.84, 1.73) 1.48 (1.03, 2.14)
≥ 75th 60 322 1.42 (0.99, 2.02) 1.46 (1.02, 2.09)
Invasive
< 50th 558 659 1.0
50th to < 75th 243 353 0.81 (0.66, 0.99)
≥ 75th 270 322 0.97 (0.80, 1.18)
75th to < 95th 209 261 0.93 (0.75, 1.15)
≥ 95th 61 61 1.14 (0.79, 1.66)
1960–1990 (≤ 20% MI)c
In situ
< 50th 25–35 289–320 1.0
50th to < 75th 23–27 136–155 1.71 (0.92, 3.19) 1.93 (1.03, 3.60)
≥ 75th 19–23 132–140 1.63 (0.87, 3.03) 1.64 (0.87, 3.09)
Invasive
< 50th 235–256 289–320 1.0
50th to < 75th 98–114 136–155 0.90 (0.65, 1.25)
≥ 75th 103–115 132–140 0.95 (0.69, 1.31)
75th to < 95th 80–92 111–121 0.95 (0.68, 1.32)
≥ 95th 21–25 19–21 1.35 (0.71, 2.56)
Abbreviations: CCA, complete case analysis; CI, confidence interval; MI, multiple imputation; OR, odds ratio.
aNumber of women with in situ cancer: 1995, n = 203; 1960–1990, n = 67–85. Number of women with invasive cancer: 
1995, n = 1,071; 1960–1990, n = 436–485. bThe ratio of the ORs compares quantile-specific effect estimates for in situ and 
invasive breast cancer (with invasive breast cancer treated as the referent group for the comparison). cCombined over 
30 imputations. Sample size varies across imputed data sets.
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deposition and decay data, proximity to inter-
sections, and background PAHs (Beyea et al. 
2006). Participants also had a wide range 
of estimated exposures due to the gradient 
of urbanization across the study area (Beyea 
et al. 2006). In addition, the LIBCSP is a 
large, population-based study with detailed 
information regarding many covariates, 
which facilitates controlling for confounders, 
assessing effect modification, and evaluating 
heterogeneity within breast cancer subtypes 
(Gammon et al. 2002a).
We estimated stronger associations 
between traffic B[a]P exposure and breast 
cancer incidence among women with low 
fruit/vegetable intake, consistent with a 
previous LIBCSP report that found that asso-
ciations with grilled/smoked meat intake—
another PAH source—were more pronounced 
among participants who consumed low 
levels of fruits/vegetables (Steck et al. 2007). 
Similarly, fruit/vegetable intake was negatively 
associated with PAH–DNA adduct levels 
measured in peripheral leukocytes, both in 
the LIBCSP (Shantakumar et al. 2005) and in 
an epidemiologic study conducted in Europe 
(Palli et al. 2000). Components of fruits and 
vegetables have antioxidant and other chemo-
preventive properties and decrease carcinogenic 
effects of PAHs in animals (Hecht 2000; Jin 
et al. 2006). To our knowledge, ours is the 
first population-based breast cancer study to 
evaluate interactions between air pollution and 
fruit and vegetable intake; thus, our results 
require confirmation. We also observed inverse 
associations between traffic and breast cancer 
in the high fruit/vegetable intake group, which 
is consistent with previous research showing 
that PAH-related tumor induction is reduced 
by high antioxidant intake (Hecht et al. 2002), 
but may also be due to chance.
Traffic B[a]P–breast cancer associations 
appeared to be stronger among premeno-
pausal women in our study, although the 
greatest difference was noted within the 75th 
to 95th percentile traffic exposure subgroup, 
rather than within the top 5%, and we also 
saw some unexpected negative associations 
between traffic exposure and breast cancer 
among postmenopausal women. Stronger 
associations with premenopausal rather than 
postmenopausal breast cancer were observed 
in previous LIBCSP reports regarding 
combined active/passive smoking exposure 
(Gammon et al. 2004) and PAH–DNA 
adducts (Gammon et al. 2002b). Similarly, 
a recent systematic review concluded that 
associations between environmental tobacco 
smoke and premenopausal, but not post-
menopausal, breast cancer were “consistent 
with causality” (Johnson et al. 2011). We 
also found stronger associations with traffic 
B[a]P among women with ER–/PR– breast 
tumors, which are overrepresented among 
premenopausal women (Chen and Colditz 
2007), although this finding was based on 
a small number of cases. Previous studies 
conducted in an area with high industrial 
emissions reported positive associations 
between air pollution and both premeno-
pausal and postmenopausal breast cancer that 
varied according to the exposure definition 
used; the associations in these studies did not 
vary by tumor hormone-receptor subtype 
(Bonner et al. 2005; Nie et al. 2007).
Associations between traffic B[a]P and 
breast cancer were stronger among women 
with in situ rather than invasive breast tumors 
when evaluating women within the top 
quantile of exposure (vs. below the median). 
A possible explanation for these findings is 
that PAHs may act earlier in the carcinogenic 
process (Millikan et al. 1995), similar to the 
way in which smoking may sometimes be 
more strongly related to colorectal adenomas, 
rather than to invasive colorectal cancer (Terry 
and Neugut 1998). Other possible explana-
tions are the influence of potential diagnostic 
bias in identifying in situ breast tumors, or 
random chance. The sample size was much 
smaller in the subgroup of participants with 
in situ breast cancer than in the subgroup of 
participants with invasive breast cancer; thus, 
the results among the in situ group are more 
unstable. In addition, we were unable to 
evaluate regressions for participants with the 
top 5% of exposures when evaluating in situ 
breast cancer owing to sample size constraints. 
Instead, we evaluated broader quantiles of 
exposure (< 50th, 50th to < 75th, ≥ 75th 
percentiles), which may have obscured some 
patterns of association. Associations between 
traffic B[a]P and invasive breast cancer were 
positive, though imprecise, among those with 
the top 5% of exposure levels, compared 
with below the median (1995: OR = 1.14, 
95% CI: 0.79, 1.66; 1960–1990: OR = 1.35, 
95% CI: 0.71, 2.56).
Traffic B[a]P was not related to tumor 
TP53-mutation status in our study, although 
the number of case women with TP53-
mutation–positive tumor tissue and high 
traffic exposure estimates was low. This null 
result was consistent with an LIBCSP report 
evaluating active and passive smoking, grilled/
smoked meat intake, and PAH–DNA adducts 
(Mordukhovich et al. 2010). Active, but not 
passive, smoking was associated with TP53-
mutation positive breast cancer in a smaller 
population study (Conway et al. 2002).
Several mechanisms potentially underlie 
the observed association between traffic-
related B[a]P, as a proxy for overall particu-
late vehicular traffic PAH exposure, and 
breast cancer incidence. PAHs are genotoxic, 
damaging DNA primarily through the forma-
tion of PAH–DNA adducts; they may also 
induce inflammation and oxidative stress, 
resulting in oxidative DNA lesions (IARC 
2010). Uncorrected DNA damage can cause 
somatic mutations in tumor suppressor genes 
or proto-oncogenes, which could in turn 
contribute to carcinogenesis (Gammon and 
Santella 2008; IARC 2010).
Limitations of our study include some 
missing address information, which was 
corrected in part through multiple imputa-
tion. Our results were robust to varying the 
percentage of imputation allowed, increasing 
confidence that our imputation method 
does not introduce artificial results (Beyea 
et al. 2013). Similarly, although analyses for 
exposure in 1960–1990 included roughly 
half of the study participants and may not 
be representative of the full study population 
(Gammon et al. 2002a), only evaluating 1 
recent year of exposure also carries implicit 
assumptions and associated biases related to 
missing exposures.
An additional limitation of our study is 
that the exposure model did not generate 
non-residential traffic PAH exposure esti-
mates. A nationwide study reported that, on 
average, American men and women spend 
almost 70% of their day inside (64.97%) or 
just outside (2.50%) of their residences, both 
throughout the United States and in one 
large city (Chicago, IL) (Leech et al. 2002). A 
Canadian study found similar results among 
women only (Nethery et al. 2009). Our results 
were not adjusted for multiple comparisons, 
although we used a targeted approach and 
carefully selected factors that were likely to 
interact with traffic PAHs. Our results may 
also be influenced by potential selection bias, 
given that our response rates among the 
control participants were lower than antici-
pated (Gammon et al. 2002a). The hormone 
receptor subtype results may be subject to 
selection bias as well, given that only a subset 
of case participants (847 out of 1,274) were 
available for these analyses. However, responses 
among the control participants are comparable 
to those among other large population-based 
case–control studies conducted in the 1990s 
(Newman et al. 1995).
The purpose of our exposure model was to 
estimate vehicular traffic PAH exposures; thus, 
by design, we did not incorporate information 
on non-traffic sources of ambient PAHs, such 
as environmental tobacco smoke, cooking, or 
heating (Beyea et al. 2013). Traffic is often the 
largest source of ambient PAHs near urban 
areas (Fromme et al. 2004; Nielsen 1996) and 
generates smaller, more inflammatory particles 
than some other ambient sources (Kocbach 
et al. 2006).
B[a]P was modeled as a surrogate for all 
traffic PAHs. Traffic pollution contains many 
chemicals, including many PAHs and other 
confirmed carcinogens (Boström et al. 2002). 
It is impossible to ascribe health effects to a 
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single traffic pollutant based on an observa-
tional study. However, B[a]P is one of the 
most carcinogenic PAHs and is representative 
of overall PAH exposure from vehicle exhaust 
(Boström et al. 2002), and particulate PAHs 
are among the most carcinogenic components 
of traffic exhaust (Boothe and Shendell 2008). 
Studies conducted throughout the United 
States indicate that historical traffic-related 
B[a]P emissions closely track emissions for all 
other measured traffic-related PAHs (Beyea 
et al. 2008). Furthermore, many types of 
traffic pollutants have differing distributions 
(Beyea et al. 2006). In our study, exposures 
were modeled using PAH-specific emissions 
data and dispersion parameters and were 
validated and calibrated against soil PAH 
levels (Beyea et al. 2006). Although studies 
of air pollution exposure and traffic pollution 
have been conducted in the United States, 
Canada, and Europe, where traffic emission 
levels are currently fairly low, future studies 
should examine associations between traffic 
exposure and breast cancer within more highly 
exposed populations.
Conclusions
We observed modest positive  associations 
between breast cancer incidence and compara-
tively high levels of residential traffic B[a]P, 
particularly among women with low fruit 
and vegetable intake and hormone receptor–
negative tumors, although the effect esti-
mates were imprecise and several exposure 
durations and participant subgroups were 
evaluated. Future studies should examine 
associations between breast cancer and traffic 
PAH exposure at different points across the 
life-course and in combination with other 
PAH sources, and should evaluate interactions 
between traffic PAHs and genetic variants in 
relevant pathways. Our results strengthen the 
plausibility of a relationship between vehicular 
traffic PAHs and breast cancer incidence and 
provide new data on potentially susceptible 
subgroups of women.
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